Treating Early Undifferentiated Arthritis: A Systematic Review and Meta ‐Analysis of Direct and Indirect Trial Evidence
ConclusionsTreating patients with UA resulted in a statistically significant delay in the development of RA, with the largest effect observed for methotrexate. These findings suggest that there is a window of opportunity to treat patients with UA early, to delay subsequent progression to RA.This article is protected by copyright. All rights reserved.
Source: Arthritis Care and Research - Category: Rheumatology Authors: Maria A. Lopez ‐Olivo, Voke Kakpovbia‐Eshareturi, Jude des Bordes, Andrea Barbo, Robin Christensen, Maria E. Suarez‐Almazor Tags: Original Article Source Type: research
More News: Abatacept | Arthritis | Databases & Libraries | Methotrexate | Methylprednisolone | Orencia | Remicade | Rheumatoid Arthritis | Rheumatology | Statistics | Study